Русский / English
Enter the query
Events
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Calendar
prev February 2019
Mon Tue Wed Thu Fri Sat Sun
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28
26.01.2015
Petrovax Pharm is selling products as part of a joint partnership with LLC Vaga Pharm, a medication supplier on the Armenian market.
More Topics Petrovax Pharm
22.01.2015
MMC Norilsk Nickel, the largest global nickel and palladium producer, reports today that it has launched the commissioning and start-up operations of the first stage of upgraded Talnakh concentrator facilities.
More Topics Norilsk Nickel / Interros
11.12.2014
Extraordinary General Meeting of Shareholders of MMC Norilsk Nickel held on December 11 approved dividend payments for 9M 2014 in the amount of RUB 762.34 per ordinary share.
More Topics Norilsk Nickel / Potanin / Interros
28.07.2014
According to Orange Book, a regular report by Synergy Research Group, Petrovax Pharm has become one of the Top 5 companies by number of clinical trials started in Q2 2014 in the Russian pharmaceuticals market.
More Topics Petrovax Pharm
12.05.2014
The immunobiological production unit of NPO Petrovax Pharm, a Russian pharmaceutical company, has produced more than 2.5 mln doses of Prevenar 13, a 13-valent conjugate pneumococcal vaccine, in easy to use disposable auto injectors. More than 5 mln doses are planned to be produced by the end of 2014.
More Topics Petrovax Pharm